We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Braintree Labs Hit With Antitrust Suit Over MiraLax

Law360 (March 13, 2007, 12:00 AM EDT) -- A New York drug cooperative has filed a proposed class action against Braintree Laboratories Inc., accusing the drug maker of conspiring to block rivals from marketing a generic version of its laxative MiraLax and improperly listing a patent with the U.S. Patent and Trademark Office.

The lawsuit, filed Monday by Rochester Drug Co-Operative Inc. in the U.S. District Court for the District of Delaware, alleges that Braintree’s anti-competitive scheme allowed it to charge supracompetitive prices for MiraLax, or polyethylene glycol 3350, an osmotic laxative that causes...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.